Janssen, L.P. - Investigator Initiated Studies Program
Janssen, L.P. - Investigator Initiated Studies Program
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| The Effect of Daratumumab in Patients With Monoclonal Gammopathy of Renal Significance (MGRS) in Finland | Blood Protein Disorders, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Hemic and Lymphatic Diseases, Male Urogenital Diseases, Urogenital Diseases, glomerulonephritis, hematologic disorder, immune system disorder, immunoproliferative disorder, kidney disorder, kidney failure, monoclonal gammopathy, nephritis, urinary system disorder | Recruiting | Phase 2 | 2026-09-16 | NCT06889948 |